CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -69.5% | 25,009 | -48.4% | 0.00% | – |
| Q2 2023 | $59 | +110.7% | 48,509 | +106.4% | 0.00% | – |
| Q1 2023 | $28 | +55.6% | 23,500 | +4.9% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 22,400 | 0.0% | 0.00% | – |
| Q3 2022 | $28,000 | +33.3% | 22,400 | 0.0% | 0.00% | – |
| Q2 2022 | $21,000 | -43.2% | 22,400 | +7.1% | 0.00% | – |
| Q1 2022 | $37,000 | +37.0% | 20,909 | +18.7% | 0.00% | – |
| Q4 2021 | $27,000 | -32.5% | 17,609 | -10.2% | 0.00% | – |
| Q3 2021 | $40,000 | -39.4% | 19,609 | +3.2% | 0.00% | – |
| Q2 2021 | $66,000 | +247.4% | 19,009 | +82.8% | 0.00% | – |
| Q1 2021 | $19,000 | +72.7% | 10,400 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |